THE RESILIENCE IMPERATIVE
The global life sciences and healthcare (LSH) industry is at a turning point. It faces a constellation of challenges that are occurring simultaneously and – taken together – constitute a seismic shift in the very nature of business.
Shrinking margins, escalating cost pressures, burgeoning regulatory and compliance requirements, changing product characteristics and growing consumerism are transforming the LSH business paradigm. What is emerging is a business model that looks and acts like the consumer goods industry, where the customer – not the manufacturer – holds the power.